Health Condition 1: null- ASA 1&2
Conditions
Interventions
Intervention1: Dexmedetomidine: Three different doses of Dexmedetomidine are compared to see which is the optimal dose that attenuates the rise in the intra ocular pressure caused by Suxamethonium
Con
Sponsors
Saswati Das
Eligibility
Inclusion criteria
Inclusion criteria: Patients willing to participate in the study ASA PS 1&2 Posted for non ophthlamic surgeries Patients with normal intra ocular pressure
Exclusion criteria
Exclusion criteria: Anticipated difficult airway Acute or chronic eye disease Patients with raised intracranial pressure Receiving any drug known to alter intra ocular pressure Pregnant and lactating patients Hypertensive patients taking any anti hypertensives Psychiatric disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Which of the three doses of Dexmetedomidine decreases the raise in intraocular pressure caused by SuxamethoniumTimepoint: 10 minutes after suxamethonium injection | — |
Secondary
| Measure | Time frame |
|---|---|
| The decrease in duration of the rise in intraocular presseure caused by suxamethoniumTimepoint: 10 minutes after Suxamethonium injection | — |
Countries
India
Contacts
Public ContactSaswati Das
Kalinga Institute of Medical Sciences
Outcome results
None listed